The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

Truly Labs AB

Han är ny ordförande för Stockholm Science City

Johan Christensen har utsetts till ny styrelseordförande för Stockholm Science City. Han efterträder Cecilia Schelin Seidegård som lämnar posten efter fem år.

Enhance your expertise with your measuring software

Discover the training options in our ZEISS Metrology Portal.

Success for Genmab's antibody-drug conjugate

The Danish company Genmab has received Japanese approval for its treatment for advanced or recurrent cervical cancer.

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

New study: Post-Covid symptoms are common even after mild Covid-19

According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...

Developing rapid diagnostics for sepsis – “Every hour counts”

Finding the right antibiotic in the right dose – with an ultra-fast analysis method. Gradientech's product solution is currently used in routine diagnostics at ...

Conference recordings now available

Don't miss out on insights from leading experts.

Elisabet Lann blir ny sjukvårdsminister

Efter det plötsliga avhoppet står det nu klar att Elisabet Lann (KD) blir ny sjukvårdsminister.

Biotages vd får gå – ”Krävs ett nytt ledarskap”

Uppsalabolaget Biotages vd och koncernchef Tomas Blomquist lämnar sitt uppdrag med omedelbar verkan efter fyra år på posten.

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

TECHNIA AB

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Pharma Outsourcing – Find the Right Partner (2026)

Elevating 3D characterization with enhanced performance and efficiencies

Introducing the ZEISS VersaXRM 730 3D X-ray microscope.

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

Anna Törner: Yes, I Am Sick, But Not Weak

”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

High-tech companies are increasingly focusing on health

Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...

Lilly recruits top Swedish researcher in Alzheimer´s

One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.

Trumps nya FDA-chef varnar för "massiv övermedicinering"

Donald Trump har nominerat kirurgen och författaren Marty Makary till ny chef för den amerikanska läkemedelsmyndigheten FDA, som enligt den tillträdande preside...

Lilly´s Nordic manager on Mounjaro launch in Sweden: "Patients deserve respect"

Another blockbuster diabetes and obesity drug has made its way into the Swedish market – with promises of a stable supply and availability for patients. “What w...